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Introduction
Several drugs, such as ergot derivatives (pergolide, cabergoline and ergotamine) (Van Camp et al., 2004; Zanettini et al., 2007) and anorectic compounds (fenfluramine and dexfenfluramine) (Connolly et al., 1997) , have been associated with remodelling of the left cardiac (mitral and aortic) valves. These drugs interact with the serotonergic system by, more precisely, targeting the 5-HT 2 receptor subtypes (5-HT 2B and 5-HT 2A ) (Fitzgerald et al., 2000; Rothman et al., 2000) , which belong to the superfamily of G q -proteincoupled receptors that activate phospholipase C. There is much evidence for the involvement of 5-HT 2 receptors in drug-induced valvular heart disease (VHD). Stimulation of 5-HT 2 receptors leads to up-regulation of target genes involved in proliferation and stimulation of valvular interstitial cells (VICs) through activation of protein kinase C, Src-protein, phosphorylation of ERK1/2 and TGF-β receptor activation Xu et al., 2002; Hutcheson et al., 2012) . Phosphorylated ERK is thought to induce TGF-β signalling and transcription of effector genes mediating myxomatous pathology (Disatian and Orton, 2009 ). Overexpression of TGF-β1 has also been implicated in cardiac diseases where fibrosis is a prominent feature. The activation of 5-HT 2B receptors in human VICs is mitogenic, resulting in ERK1/2 phosphorylation and incorporation of [ 3 H]-deoxythymidine (Setola et al., 2003) and has also been implicated in 5-HT-induced valvulopathy in experimental animals (Elangbam et al., 2008) . The 5-HT 2B receptor appears enriched in heart valves from various species including dog (Oyama and Chittur, 2006; Lu et al., 2015; Cremer et al., 2015a) , rat (Elangbam et al., 2005) , pig (Fitzgerald et al., 2000; (Cremer et al., 2015b) and human (Fitzgerald et al., 2000) , mainly in healthy tissues. Nevertheless, 5-HT receptors other than the 5-HT 2B subtype have been reported in valve tissue (Lu et al., 2015; Cremer et al., 2015b) , and the involvement of the 5-HT transporter (SERT) in VHD has been suggested by the development of valvular fibrosis in SERT knockout (KO) mice (Mekontso-Dessap et al., 2006) . Moreover, the wellknown 'carcinoid heart', a valvulopathy associated with excess of plasma (free) 5-HT secreted by neuroendocrine tumours, highlights the important role of this biogenic amine in VHD (Lundin et al., 1988) . Although earlier work has linked 5-HT 2 receptors to VHD, these links are not as strong as they may appear. For instance, many experiments were performed with healthy tissues (Fitzgerald et al., 2000; Setola et al., 2003) , making difficult the extrapolation to pathological mechanisms. Stimulation with 5-HT was performed with high concentrations (≥10 6 M) over a long period Xu et al., 2002; Elangbam et al., 2008) and 5-HT 2 receptor agonists applied in vitro to valve tissues induced relatively small effects (Barzilla et al., 2010) . Taking all these limitations into consideration, we hypothesized that the 5-HT 2 receptor stimulation involved in VHD could take place in sites other than the valve itself and that receptors other than the 5-HT 2B subtype could also be involved. Cardiac valves are made of valvular endothelial (VECs) and interstitial cells (VICs). Both cell types are required for the homeostatic maintenance of valve tissue, which is exposed to high haemodynamic constraints. These two cell populations are heterogeneous. VICs can be found quiescent with a fibroblast phenotype or activated with various markers typical of myofibroblasts, stem cells and osteoblasts (Liu et al., 2007) . Progenitor VICs were also observed in response to injury, but their origin and the mechanism underlying the repair are not yet known (Liu et al., 2007) . Some VECs are able to synthesize extracellular cell matrix (ECM) and to populate and assemble all three valve layers. Valve endothelium is absolutely required to renew the population of VICs from endothelial progenitors (Paruchuri et al., 2006) . Nevertheless, the origin of these last cells and the mechanism(s) by which they reach the valve is also not known. Here, we have tested the possibility that 5-HT stimulation could be involved in VHD through the mobilization of endothelial progenitors in cardiac valve tissue. In fact, some authors described rapid migration of bone marrow (BM)-derived cells in mitral valve tissue after engraftment of fluorescent cells in wild-type (WT) mice (Visconti et al., 2006) showing, in basal homeostatic conditions, the recruitment of precursor cells to the valvular tissue. These cells could constitute part of a so-called 'VECs reservoir' of endothelial progenitors that would then transdifferentiate via the general process of endothelial to mesenchymal transition (Paranya et al., 2001; Paruchuri et al., 2006) . In the first approach of this study, using pharmacological and transgenic mice experiments, we investigated the contribution of 5-HT 2B receptors in drug-induced valvulopathy, in terms of endothelial progenitor mobilization. In the second part, the association between mitral valve prolapse and activation of platelets (Walsh et al., 1981; Martini et al., 1996) , as the main cellular store of 5-HT in the periphery, led us to investigate if similar mechanisms could be involved in human VHD.
Methods

Animals
All animal care and experimental procedures were performed in accordance with the guidelines for animal experimentation of the European Communities Council Directive EU/63/2010 and appropriate approval with the authorization number AL/81/88/02/13. Animal studies are reported in compliance with the ARRIVE guidelines (Kilkenny et al., 2010; McGrath and Lilley, 2015) . Studies were performed in 12-week-old male mice. WT 129S2/SvPasCrl mice were purchased from Charles River Laboratories (L'Arbresle, France ). Ritanserin dose and administration route were validated by a platelet aggregation test (Supporting Information Figure S1 ). Ritanserin and pCPA were added to food pellets. Sarpogrelate, SB204741 and SB206553 were infused by the mean of a second osmotic pump. Food and water intake were controlled together with body weight to adjust p.o. delivered drugs (Supporting Information Figure S2 ).
Six groups of transgenic mice were studied:
À/À vehicle and (vi) Htr 2A/2B À/À NdF. All groups were monitored weekly for systolic BP and heart rate (HR) by tail-cuff photoplethysmography (BP-2000, Visitech, Apex, NC, USA) (Supporting Information Figure S4 ). Transthoracic echocardiography was performed 1 day before the beginning of the experiments (day À1) and after 28 days of treatment (in WT and NdF mice groups, Table 1 ). At day 27, urinary 5-hydroxyindoleacetic acid (5-HIAA) was measured from 0.5 to 1.0 mL urine collected in a tube protected against light and containing a drop of 5 N HCl in mice housed individually in metabolic cages overnight (18:00 to 08:00 h). At day 28, at the end of the last echocardiography and during isoflurane anaesthesia, 0.5 mL blood was collected by intracardiac puncture, before giving a lethal i.p. injection of pentobarbital (150 mg·kg À1 , CEVA Santé Animale, Libourne, France). Hearts harvested from mice were immediately rinsed, weighed (Supporting Information Figure S3 ) and fixed with 10% formalin solution before being processed. WT-C (n = 10) WT-NdF (n = 10) P value WT-C (n = 10) WT-NdF (n = 10) P value BW (mg) 30 ± 0.6 28 ± 0.6 ns 30 ± 0.9 29 ± 0.9 ns 
Biochemical measurement
HW/BW (mg·g À1 ) - - - 5
Histology and quantification of mitral valve lesions
Fixed mouse hearts were paraffin embedded, sectioned at 4 μm (using HM 355S Automatic Microtome) and stained with haematoxylin and eosin. Sections were performed so as to obtain four-chamber views of the heart with long-axis section of the tricuspid, mitral and aortic leaflets. A single operator (R.L.), blinded to the experimental groups, performed valve morphometric analysis with a microscope (Carl Zeiss, Jena, Germany) equipped with a 40× calibrated objective giving; at this magnification, a large square of 250 × 250 μm divided in 100 equal parts of 25 × 25 μm each. NdF induced non-reproducible lesions of the aortic valve and no alteration of the tricuspid one in our conditions. Therefore, we decided to focus on the mitral valve. For quantification, the whole mitral valve leaflet section was divided in three equal segments: proximal (near the insertion), medial and distal (including the tip). The thickness of each segment is the mean value obtained in three distinct sites. The surface cell density was determined on the whole segment (mean value of three distinct sites), and the result expressed in number of cells per 0.01 mm 2 .
Immunohistochemistry was performed on paraffinembedded samples with anti-Ki-67 (Mib1, 1/100, USBiological, Salem, MA, USA) and anti-CD34 (EP373Y, 1/100, Genetex, Irvine, CA, USA) antibodies.
Bone marrow (BM) transplantation
As previously described, thirteen 8-week-old WT male mice were subjected to 9.5 Gray lethal total body irradiation (Potteaux et al., 2006) . The following day, mouse BM was reconstituted by direct i.v. injection with 2.5 × 10 6 cells of freshly isolated BM from femurs and tibias of age and sexmatched WT or Htr 2B À/À mice. All lethally irradiated and transplanted mice survived, revealing the efficiency of BM reconstitution by either WT (n = 6) or Htr 2B À/À (n = 7) BM. After 4 weeks of recovery, transplanted mice were then exposed to NdF and followed the same protocol applied to other groups.
Blood mobilization of progenitors and bone marrow analysis
To analyse the effects of NdF on the mobilization of progenitor cells in the blood and BM, WT control (WT-C) and Htr 2B 
Human mitral valve tissues
Eighteen human degenerative heart valves were obtained from patients referred to the Department of Cardiovascular Surgery, University Hospitals of Strasbourg, France, for a cardiac valve replacement (mitral valve prolapsed diagnosis).
All patients authorized the subsequent use of their valve tissues for research purpose and the protocol was approved by the Ethics Committee of the Faculty of Medicine of Strasbourg (6 December 2011).
Valve histology and immunohistochemistry analysis
Human mitral valve tissues (n = 4) were fixed with formalin solution for 2 days and embedded in paraffin; 4 μm slices were stained with Alcian blue and haematoxylin and eosin to identify valve lesions and evaluate cellular density.
Immunostaining was performed to localize 5-HT 2B receptors (A72-1, BD Pharmingen, BD Biosciences, Le Pont de Claix, France) and CD34 progenitors (QBEnd 10, Dako®, Glostrup, Denmark). Finally, Ki-67 was used as a marker of cell proliferation (MIB-1, Dako, Santa Clara, CA, USA).
Immunostaining was performed using a biotin-labelled peroxidase-conjugated secondary antibody incubated with diaminobenzidinetetrahydrochloride as a final chromogen (Ultraview DAB Detection Kit, Roche®, Tucson, Arizona, USA). Labelling control was performed by incubating only the secondary antibody. Cell count was performed with a microscope (Carl Zeiss, Jena, Germany) equipped with a 40× calibrated objective giving, at this magnification, a large square of 250 × 250 μm divided in 100 equal parts of 25 × 25 μm each. The surface cell density was determined at the endothelium, sub-endothelium and spongiosa levels, and the results expressed in number of cells per 0.01 mm 2 .
To quantify immunostained cells, results were expressed as a percentage of positive cells compared with total cells per 0.01 mm 2 (5-HT 2B receptor, CD34 and Ki-67). The number of total or labelled cells in valve lesions is the mean value obtained in three distinct sites per valve.
Mitral valvular cells isolation and flow cytometry and magnetic cell sorting
To remove cells from mitral valve tissues, specimens were immersed in a collagenase solution (NB8 Broad range 1 mg·mL À1 ; Serva, Coger, Paris, France) for 2 h at 37°C. Tissue pieces were scrubbed through a 70 μm strainer, and cell suspension was filtered to remove debris. In a first set of experiments, using eight mitral valves, single-cell suspensions were labelled with CD34-Alexa Fluor 647-conjugated antibody ( 
Immunocytochemical staining
To identify the expression of 5-HT 2B receptors in endothelial cells, the whole cell suspension obtained after human mitral valve collagenase treatment was stained with antibodies against the 5-HT 2B receptor and some other surface markers (n = 3 mitral valves). Briefly, cells were plated and cultured overnight at 37°C, 5% CO 2 with DMEM/F12 receptor) (average of five fields per valve) were counted by bright field and UV illumination.
Data analysis and statistics
The data and statistical analysis comply with the recommendations on experimental design and analysis in pharmacology (Curtis et al., 2015) . For data from mice, values are expressed as mean ± SEM. Statistical comparisons between two or more groups were performed when appropriate using Student's unpaired t-tests or one-way ANOVA followed by post hoc analysis with Dunnett's or Fisher's least significant difference test (GraphPad Software version 6.0). P < 0.05 was considered statistically significant. For data from the human samples, values are expressed as mean ± SEM. Statistical comparisons between two or more groups were performed when appropriate using Student's unpaired t-tests or non-parametric tests (Kruskal-Wallis) (GraphPad Software version 6.0). P < 0.05 was considered statistically significant.
Materials
All drugs and chemicals used in these experiments were purchased from Sigma-Aldrich (Saint-Quentin-Fallavier, France), unless otherwise indicated.
Nomenclature of targets and ligands
Key protein targets and ligands in this article are hyperlinked to corresponding entries in http://www. guidetopharmacology.org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Southan et al., 2016) , and are permanently archived in the Concise Guide to PHARMACOLOGY 2015/2016 (Alexander et al., 2015a,b,c) .
Results
Chronic administration of nordexfenfluramine induces mitral valve remodelling
Infusion of NdF for 28 days did not modify body weight, systolic arterial BP, HR and echocardiographic parameters (Table 1 and Supporting Information Figures S2-S4) . In particular, no cardiac remodelling and/or systolic dysfunction was observed. Whole blood 5-HT and urinary 5-HIAA assays revealed an increase in 5-HT turnover with a twofold augmentation of 5-HIAA, while blood 5-HT concentration remained unchanged (Table 2) . WT-C mice presented a homogenous and thin valve architecture bordered by regular endothelial CD31 + lining (data not shown) and only few CD34 + cells ( Figure 1F ). Conversely, we observed segmental thickened (84%) and retracted leaflets in WT-NdF animals ( Figure 1A , B) with increased endothelial cell number bordering the valves ( Figure 1A, C) . Concerning interstitial cell density, no significant change was observed between WT-NdF and WT-C ( Figure 1A, D) . Finally, clusters of rounded shape cells positive for the CD34 antigen were observed ( Figure 1F ). However, similarly to the WT-C group, in WT-NdF mitral valves, only few nuclei were Ki-67 positive indicating a low rate of proliferation ( Figure 1E ). (Table 3) . Sarpogrelate treatment also prevented valve injuries induced by NdF (Figure 2 ). However, we detected a significant increase thickness with Htr 2A À/À mice under NdF treatment (31%) ( Figure 3B , G). To test the contribution of 5-HT 2B receptors, we evaluated NdF effects in WT mice co-treated with SB204741 or SB206553, two 5-HT 2B receptor antagonists or in Htr 2B À/À mice. In WT mice, NdF-induced urine 5-HIAA increase was prevented by SB204741 co-treatment, but not blocked by SB206553. Blood 5-HT concentration was not statistically different from WT-NdF group (Table 2) . Htr 2B À/À mice had higher basal urinary 5-HIAA, which was not affected by NdF treatment (Table 3) . SB204741 and SB206553 treatments prevented valve injuries induced by NdF (Figure 2) . Furthermore, no lesion was detectable in Htr 2B À/À mice under NdF treatment ( Figure 3C, D, H, K, N) . To test the contribution to lesions of both 5-HT 2B and 5-HT 2A receptor blockade, we evaluated NdF effects in WT mice co-treated with ritanserin, a non-selective murine 5-HT 2 receptor antagonist or in Htr 2A/2B À/À double mutants. NdF-induced urine 5-HIAA increase was blocked by ritanserin co-treatment. Peripheral blood 5-HT concentration was not statistically different (Table 2) . Htr 2A/2B À/À double mutant mice had a twofold increase of urine 5-HIAA under NdF treatment and significantly lower blood 5-HT compared with their control group (Table 3) . Histological lesions were fully prevented by ritanserin (Figure 2 ). Histological and morphometric analysis of Htr 2A/2B À/À mice mitral valve did not reveal any lesion ( Figure 3E, F, I , L, O). These results confirm the role of both 5-HT 2A and 5-HT 2B receptors in valve remodelling with a major contribution of the 5-HT 2B receptor subtype, based on the increased thickness of valve tissue observed in Htr 2A
À/À mice.
Taking into account that NdF induces 5-HT release by platelets through its interaction with the SERT, we investigated whether the levels of free 5-HT contributes to NdFinduced valve remodelling. We induced a peripheral 5-HT depletion by treating mice with 100 mg·kg À1 ·day À1 of pCPA, a tryptophan hydroxylase inhibitor. Chronic pCPA markedly decreased blood 5-HT (3×) and urinary 5-HIAA (Table 2) . Nevertheless, this massive depletion failed to prevent the remodelling of valve leaflets induced by NdF (Figure 2 ). This result indicates that increased peripheral 5-HT is not necessary for NdF-induced mitral valve injuries and that the direct 5-HT 2B receptor stimulation by NdF is sufficient to trigger valve remodelling. Taking into account that mitral valve lesions show a low rate of proliferation but are highly cellularized (CD34 + cells), we hypothesized that these cells could be recruited at the valve surface from the blood stream after being mobilized from the BM.
5-HT 2B receptors are involved in the mobilization of endothelial progenitors from the bone marrow
To test this hypothesis, we compared the effect of a chronic NdF treatment in lethally irradiated WT mice engrafted with a Htr 2B À/À BM with the effects of a similar treatment in WT mice engrafted with a WT BM. Mice transplanted with WT BM exhibited histological lesions with a significant increase of the thickness (28.4%) and endothelial cell density in the mitral valves ( Figure 4A, C) . By contrast, histological lesions were totally absent from mice that received BM from Htr 2B À/À mice ( Figure 4B, C) . Therefore, the ablation of 5-HT 2B receptors, restricted to BM, prevents the increase in thickness and endothelial cellularity of mitral valves, supporting the contribution of 5-HT 2B receptors to the mobilization of BM-derived endothelial progenitors.
Whole-body irradiation probably affects the repopulation of the BM in non-haematopoietic cells leading to a reduction of the BM mobilization capabilities of endothelial progenitors in WT_WT mice. Table 2 Blood 5-HT and urinary 5-HIAA in WT mice
Stimulation of BM 5-HT
WT-C (n = 9)
WT-NdF (n = 10)
WT-S (n = 9)
WT-SB204 (n = 10)
WT-SB206 (n = 10)
WT-R (n = 10)
WT-P (n = 9) NdF injection induced, a significant increase in the number of free (i.e. released from the ECM) CD34 + /CD31 + cells ( Figure 5A ), which was associated with an increase in actin polymerization in these cells, as shown by phalloidin labelling ( Figure 5B ). Simultaneously, a significant increase in circulating CD34 + /CD31 + cells was observed in the blood of these animals ( Figure 5C ). Conversely, NdF did not produce these events in Htr 2B À/À mice. This reduction of migration capabilities is probably at the origin of the higher number of these cells found in the BM in basal conditions. These data support the idea that NdF induces endothelial progenitors mobilization by a 5-HT 2B receptor-dependent mechanism and that NdF triggers the acute mobilization of CD34 + / CD31 + cells from BM into the blood. These cells then home into target tissues that require homeostatic repair.
In the second part of this work, we assessed the possibility of a similar mechanism, triggered by endogenous 5-HT, being involved in spontaneous human mitral valve degeneration.
Identification of CD34
+ cells sharing the 5-HT 2B receptor in human mitral valve lesions Figure 7A , B).
The CD34/CD31 labelling identified three major cell populations, that is, CD34 + /CD31 Figure 7C ). In isolated valve cells, using double immunocytochemical staining with anti-5-HT 2B receptors and anti-CD34 antibodies, we confirmed at the protein level that all CD34 + cells express 5-HT 2B receptors ( Figure 7D ). To confirm the endothelial commitment of the CD34 + cell population, we used MACS with a CD34 antibody conjugated to magnetic beads. We obtained a homogenous cell population with more than 95% CD34 + cells. Among this population, the co-labelling using another anti-CD34 and an anti-CD309 (VEGFR2) antibodies revealed about 80% double positive cells in mitral valves ( Figure 7E, F (Maroteaux et al., 2017) . In the liver, genetic suppression or antagonists of 5-HT 2B receptors limited CCL4-induced fibrogenesis by blocking TGF-β secretion by stellate cells (Ebrahimkhani et al., 2011) . Similarly, in the skin, pharmacological inactivation of 5-HT 2B receptors Table 3 Blood 5-HT and urinary 5-HIAA in transgenic mice
NdF (n = 11) C (n = 7) NdF (n = 9) C (n = 10) NdF (n = 9) BJP E Ayme-Dietrich et al.
reduces dermal fibrosis in models where a contribution from platelet 5-HT is highly likely (Dees et al., 2011) . Nevertheless, fibrotic side effects induced by stimulation of 5-HT 2B receptors were more frequently reported in lung and cardiac valve tissues. The hepatic de-ethylated dexfenfluramine metabolite, NdF, shows a high affinity for the 5-HT 2B receptor (K i = 11.2 ± 4.3 nM), 5-HT 2C receptor (K i = 324 ± 7.1 nM) and a lower affinity towards the 5-HT 2A subtype (K i = 1516 ± 88 nM) (Rothman et al., 2000) . Given chronically to mice, this compound induced VHD, comparable to the valve lesions induced by the ergot derivatives. NdF induced nonreproducible lesions of the aortic valve in this model. Species differences, haemodynamics and/or embryological origin of valve cells could explain some differences related to the response of these two valves to the treatments. Here, we show that these lesions appear as a result of the stimulation, chiefly of 5-HT 2B receptors, with some contribution of 5-HT 2A receptors as demonstrated by antagonist treatments (SB204741, SB206553, sarpogrelate and ritanserin) and transgenic mice experiments (Htr 2B À/À and Htr 2A/2B À/À ). These data confirm previous results showing that cyclic stretch in porcine valve cusps increases proliferation and extracellular matrix remodelling, through up-regulation of the mRNA for 5-HT 2A and 5-HT 2B receptors (Balachandran et al., 2011) and emphasize that both receptors are required for VHD. A low level of increased mitral valve thickness persisted in Htr 2A À/À transgenic mice. Taking into account that the same endothelial cellularity was measured in Htr 2A À/À transgenic mice, with or without treatment with NdF, it is possible that a local 5-HT 2B compensatory overexpression could contribute to collagen synthesis and extracellular matrix remodelling in these particular animals (Balachandran et al., 2012) . Some authors have suggested that fenfluramine effects could be, at least in part, mediated by peripheral and central 5-HT release following direct action on SERT (Rothman et al., 2010) . This endogenous, locally released 5-HT could explain non-5-HT 2B receptor mediated effects in valve tissue. Nevertheless, in our study, marked depletion of peripheral 5-HT induced by pCPA failed to prevent remodelling of valve leaflets induced by NdF, indicating that peripheral 5-HT was not necessary for NdF to induce mitral valve damage and that direct stimulation of 5-HT 2A/2B receptor by NdF is sufficient to trigger valve remodelling.
In this study, we showed, in mice, that the valve lesions contain a large number of CD34 + cells, confirming previous studies showing that haematopoietic stem cells contribute to the fibroblast population of adult valves (Visconti et al., 2006) . 5-HT can promote the differentiation of progenitor cells (Hirota et al., 2014) . These data support the idea that 5-HT through 5-HT 2B receptor stimulation could induce maturation of progenitor cells in the valve tissue and/or their mobilization from the BM followed by their recruitment into the valves. We investigated the last hypothesis in the NdF mouse model. triggered by 5-HT receptor agonists. In addition, this work makes a parallel with pulmonary hypertension in which a similar mechanism involving BM progenitors was previously demonstrated (Launay et al., 2012) . The contribution of circulating cells originating from the BM to fibrosis has been suggested in tumours (Quante et al., 2011) but also in a nontumour tissue such as the liver (Abe et al., 2001; CastilhoFernandes et al., 2011) . In this last tissue, myofibroblasts originate at least in part from cells coming from the BM (Brenner et al., 2012) . Values are means ± SEM (n = number of animals per group). *P < 0.05, significantly different from mice transplanted with WT BM; unpaired Student's t-test.
The migration of BM-derived endothelial progenitors is supported by results from earlier studies. Vaturi et al. (2011) observed a reduction of blood endothelial progenitors in patients with aortic stenosis that was interpreted as a deffect on the repair process. Nevertheless, we could postulate that this decrease is in fact due to the recruitment of these cells in the injured tissue. Similarly, in severe aortic stenosis, blood endothelial progenitors decrease to below the control level (Matsumoto et al., 2009) . Stimulation by 5-HT could favour mobilization and/or recruitment of endothelial progenitors, as reported in accelerated mitral valve bioprosthesis degeneration which was induced by benfluorex, an NdF precursor (Ayme-Dietrich et al., 2012) . The non-cellularized collagen matrix was rapidly colonized and developed typical myxomatous lesions. In our work, a single NdF injection rapidly triggered the increase of CD34 + /CD31 + cells in BM and blood.
These cells were released from the BM matrix and migrated after cytoskeleton activation. The NdF-induced blood mobilization from BM was prevented in Htr 2B À/À mice. Both of these effects involved 5-HT 2B receptors as they were totally absent from Htr 2B À/À mice. Interestingly, BMPR2, a TGF-β1 highaffinity receptor, mutations are associated with heritable pulmonary arterial hypertension (Deng et al., 2000; International PPH Consortium et al., 2000) . Mice bearing the R899X mutation in the BMPR2 gene (loss of function) develop spontaneous pulmonary hypertension that is prevented by the 5-HT 2B receptor antagonist, SB204741 (West et al., 2016) , or by transplantation of WT BM (Yan et al., 2016) . Similarly, animals lacking BPMR2 in endothelial progenitors develop a valvulopathy that closely mimics the one we obtained following NdF infusion (Beppu et al., 2009 ). This common mechanism of 5-HT 2B receptor-mediated mobilization of endothelial progenitors from BM could explain why valvulopathies are frequently associated with pulmonary hypertension. Therefore, we propose that 5-HT 2B receptors by regulating BMPR2/Src signalling regulates cytoskeletal genes and function in endothelial progenitor cells, leading to their mobilization from the BM and their subsequent recruitment to pulmonary vessels and cardiac valves.
In (Balaji et al., 2013) or haematopoietic, when they lack vessel-forming activity (Case et al., 2007) . The CD34 transmembrane molecule is expressed by precursors of both endothelial cells and fibroblasts (Lanza et al., 2001 ). Few reports had described CD34 + labelling in the spongiosa and fibrosa layers of the valves (Barth et al., 2005) and assumed that it corresponds to mesenchymal cells proliferating in the tissue. In the same paper, these authors also analysed 10 so-called normal mitral valves obtained from 41-to 85-year-old patients who had died from noncardiovascular causes. Immunohistochemistry identified CD34 + cells in the spongiosa. Their photomicrographs also showed a positive staining at the endothelial surface, arguing in favour of a recruitment followed by migration in the spongiosa. So, it is likely that CD34 + cells are present in the 'normal' mitral tissue and their number is increased in the pathological state. The low rate of cell proliferation + /CD31 + cells, whereas no change was noticed in cells of Htr 2B À/À mice (B). Simultaneously, in the WT mice, the single NdF injection induced a significant increase in endothelial progenitors, whereas the amount of these progenitors in the blood of Htr 2B À/À mice did not change (C). These data suggest that endothelial progenitors mobilization by NdF is a 5-HT 2B receptor-dependent mechanism and originates from the BM. Values are means ± SEM (n = number per group). non-parametric Mann-Whitney U-test is shown by * P < 0.05 and # P < 0.05, significantly different from WT-C. NS, not significant.
supported that the high cell content of the pathological samples was due to migration instead of local proliferation. Based on CD34 expression, we identified two main cell populations, from collagenase-treated human mitral valve samples, that is, CD34 + /CD31 À and CD34 À /CD31 À . The CD34 + /CD31 + cells probably correspond to differentiating endothelial cells (Murohara, 2001) . The most prevalent CD34 + /CD31 À population comprised 60-85% of cells that coexpressed CD309/VEGFR2 and NOS3, strongly suggesting that they are endothelial cell progenitors (Schatteman et al., 2007) . Nevertheless, the definition of an endothelial progenitor is still matter of debate and is used to describe cell types included in the 'proangiogenic haematopoietic progenitor cells' family (Asahara et al., 1997) . Some of these cells are involved in neoangiogenesis but others lack pro-angiogenic capabilities (Wara et al., 2011) In conclusion, our present results demonstrate that 5-HT and 5-HT 2B receptors are involved in early processes of valve remodelling. The cellular mechanism involves mobilization from the BM of endothelial progenitors expressing the 5-HT 2B receptor. These cells are then recruited to the valve where they later undergo differentiation to myofibroblast or other cell types to propagate valve lesions, in an irreversible step. This work opens new fields with potential clinical consequences. First, it strongly suggests that the screening of drugs and their metabolites acting on BM-derived endothelial progenitors via 5-HT 2B receptors or other targets could be useful to predict valve and pulmonary side effects. Such screening would be done in preclinical models (Whitebread et al., 2016) . Second, it opens the way to search for antagonists of the 5-HT 2A and/or 5-HT 2B receptors to protect, reverse or slow down early steps of cardiac valve degeneration, in patients at risk.
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